Congenital insensitivity to pain

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Congenital insensitivity to pain
Video showing a person with congenital insensitivity to pain
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Inability to feel pain
Complications Injury, burns, bone fractures
Onset Birth
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Injury due to lack of pain sensation
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis Congenital analgesia, Hereditary sensory and autonomic neuropathy
Prevention N/A
Treatment Protective measures, injury prevention
Medication N/A
Prognosis Varies depending on management of injuries
Frequency Rare
Deaths N/A


Congenital insensitivity to pain (CIP), also known as congenital analgesia, is a rare genetic disorder that inhibits the ability to perceive physical pain.

Introduction[edit]

People with this condition can feel touch, but they cannot feel pain. This can lead to an accumulation of injuries and health issues over time. The condition is present from birth and is usually identified in infancy.

Causes[edit]

CIP is caused by mutations in the SCN9A gene. This gene provides instructions for making a protein that is critical for the normal function of nerves that transmit pain signals. Mutations in the SCN9A gene result in the production of a nonfunctional protein, which prevents these nerves from transmitting pain signals properly.

Symptoms[edit]

The primary symptom of CIP is an inability to feel pain. This can lead to a variety of complications, including frequent injuries, burns, and bruises. Individuals with CIP may also have a reduced sense of smell (anosmia).

Diagnosis[edit]

Diagnosis of CIP is based on the clinical symptoms and confirmed by genetic testing. The genetic testing can identify mutations in the SCN9A gene.

Treatment[edit]

There is currently no cure for CIP. Treatment is focused on managing the symptoms and preventing injuries. This may include regular check-ups, use of protective gear, and education about the condition.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.